Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility

Inhibition of ADP-ribosylation factor-like 6 interacting protein 1 suppresses proliferation and reduces tumor cell invasion in CaSki human cervical cancer cells

(2010) Fengjie Guo et al.   MOLECULAR BIOLOGY REPORTS

CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations

(2009) Georgina L. Hold et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Single-Nucleotide Polymorphisms in Genes Encoding Toll-Like Receptor -2, -3, -4, and -9 in Case–Control Study with Breast Cancer

(2009) Godfrey E. Etokebe et al.   Genetic Testing and Molecular Biomarkers

Impact of Toll-like receptors [TLR] 2 (−196 to −174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women

(2009) Saumya Pandey et al.   GYNECOLOGIC ONCOLOGY

Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate–gene association study

(2009) Vassiliki Mollaki et al.   JOURNAL OF HUMAN GENETICS

Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-κB in prostate cancer cells

(2009) Jin Ming Di et al.   MOLECULAR BIOLOGY REPORTS

Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway

(2008) Qun Jiang et al.   BMC CANCER

Toll-like receptor polymorphisms and susceptibility to human disease

(2008) E. Ann Misch et al.   CLINICAL SCIENCE

Increased expression of Toll-like receptors 4 and 9 in human lung cancer

(2008) Yan-Bei Zhang et al.   MOLECULAR BIOLOGY REPORTS

Polymorphisms in Toll-like receptor genes and risk of cancer

(2008) E M El-Omar et al.   ONCOGENE

The Effect of Toll-Like Receptors and Toll-Like Receptor Genetics in Human Disease

(2007) Stavros Garantziotis et al.   Annual Review of Medicine

Increased expression of Toll-like receptor 5 during progression of cervical neoplasia

(2007) W.Y. KIM et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER